Jagadheshan Hiriyan

Ragaglitazar: a novel PPAR<i>α</i> &amp; PPAR<i>γ</i> agonist with potent lipid‐lowering and insulin‐sensitizing efficacy in animal models

Ranjan Chakrabarti, Reeba K. Vikramadithyan, Parimal Misra et al. · British Journal of Pharmacology · 2003 · 79 citations · Full text

PAT5A: A Partial Agonist of Peroxisome Proliferator-Activated Receptor γ Is a Potent Antidiabetic Thiazolidinedione Yet Weakly Adipogenic

Parimal Misra, Ranjan Chakrabarti, Reeba K. Vikramadithyan et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 59 citations

Nephroprotective activity of Combretum micranthum G. Don in cisplatin induced nephrotoxicity in rats: In-vitro, in-vivo and in-silico experiments

Mabozou Kpemissi, Kwashie Eklu‐Gadegbeku, Veeresh Prabhakar Veerapur et al. · Biomedicine & Pharmacotherapy · 2019 · 52 citations · Full text

Antidiabetic and hypolipidemic potential of DRF 2519—a dual activator of PPAR-α and PPAR-γ

Ranjan Chakrabarti, Parimal Misra, Reeba K. Vikramadithyan et al. · European Journal of Pharmacology · 2004 · 43 citations

Molecular Pharmacology, Metabolic Syndrome, Molecular Physiology +12

ERK1/2 activated PHLPP1 induces skeletal muscle ER stress through the inhibition of a novel substrate AMPK

Soma Behera, Bandish Kapadia, Vasundhara Kain et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2018 · 29 citations

Muscle Function, Signal Transduction, Molecular Physiology +10